Trial ChiCTR2000029496
Publication Zheng F, Int J Infect Dis, 2020
Primary outcome on the report: The SARS-CoV-2 clearance rates in COVID-19 patients assessed on day 6 of antiviral treatment.

Note: The risk of bias by domain corresponds to the highest risk of bias among outcomes by domain.
The overall risk of bias corresponds to the overall highest risk of bias assessed among outcomes.